L. Edwards
Vermogen: 2 M $ op 30-06-2026
Vermogen: 2 M $ op 30-06-2026
Mr. L.
T.
Edwards is a Chief Commercial Officer & Executive VP at Arcutis Biotherapeutics, Inc. Mr. Edwards was previously employed as a Vice President & Head-Immunology Business by Incyte Corp.
and a Vice President-Immunology by UCB, Inc. He received his undergraduate degree from East Tennessee State University and an MBA from Embry-Riddle Aeronautical University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 08-04-2026 | 59.928 ( 0,05% ) | 2 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 27-09-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | - |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 5 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
East Tennessee State University
East Tennessee State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Embry-Riddle Aeronautical University
Embry-Riddle Aeronautical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau